WO2001065265A1 - Dispositif de test biologique ou chimique - Google Patents
Dispositif de test biologique ou chimique Download PDFInfo
- Publication number
- WO2001065265A1 WO2001065265A1 PCT/FR2001/000580 FR0100580W WO0165265A1 WO 2001065265 A1 WO2001065265 A1 WO 2001065265A1 FR 0100580 W FR0100580 W FR 0100580W WO 0165265 A1 WO0165265 A1 WO 0165265A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- fluid
- capillary
- chamber
- test
- tested
- Prior art date
Links
- 238000013098 chemical test method Methods 0.000 title 1
- 239000012530 fluid Substances 0.000 claims abstract description 114
- 238000012360 testing method Methods 0.000 claims abstract description 58
- 238000011144 upstream manufacturing Methods 0.000 claims abstract description 30
- 238000006243 chemical reaction Methods 0.000 claims abstract description 22
- 210000004369 blood Anatomy 0.000 claims description 42
- 239000008280 blood Substances 0.000 claims description 42
- 239000003795 chemical substances by application Substances 0.000 claims description 27
- 239000003153 chemical reaction reagent Substances 0.000 claims description 22
- 239000000463 material Substances 0.000 claims description 9
- 229920003023 plastic Polymers 0.000 claims description 8
- 230000015572 biosynthetic process Effects 0.000 claims description 5
- 238000000034 method Methods 0.000 claims description 5
- 230000000694 effects Effects 0.000 claims description 4
- 239000012895 dilution Substances 0.000 claims description 3
- 238000010790 dilution Methods 0.000 claims description 3
- 210000003743 erythrocyte Anatomy 0.000 claims description 3
- 238000012423 maintenance Methods 0.000 claims description 3
- 239000004033 plastic Substances 0.000 claims description 3
- 239000000725 suspension Substances 0.000 claims description 3
- 230000000007 visual effect Effects 0.000 claims description 3
- 239000013060 biological fluid Substances 0.000 claims description 2
- 230000002427 irreversible effect Effects 0.000 claims description 2
- 238000005070 sampling Methods 0.000 claims description 2
- 238000003466 welding Methods 0.000 claims description 2
- 230000001939 inductive effect Effects 0.000 claims 1
- 238000009434 installation Methods 0.000 claims 1
- 239000000203 mixture Substances 0.000 description 8
- 230000004520 agglutination Effects 0.000 description 6
- 239000000126 substance Substances 0.000 description 6
- 239000000427 antigen Substances 0.000 description 3
- 102000036639 antigens Human genes 0.000 description 3
- 108091007433 antigens Proteins 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 238000000465 moulding Methods 0.000 description 3
- 230000005484 gravity Effects 0.000 description 2
- 230000035484 reaction time Effects 0.000 description 2
- 239000004793 Polystyrene Substances 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 238000004820 blood count Methods 0.000 description 1
- 238000009534 blood test Methods 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 238000007705 chemical test Methods 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 229920002457 flexible plastic Polymers 0.000 description 1
- 239000000644 isotonic solution Substances 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 229920003229 poly(methyl methacrylate) Polymers 0.000 description 1
- 229920005668 polycarbonate resin Polymers 0.000 description 1
- 239000004431 polycarbonate resin Substances 0.000 description 1
- 239000004926 polymethyl methacrylate Substances 0.000 description 1
- 229920002223 polystyrene Polymers 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 239000000376 reactant Substances 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 238000013518 transcription Methods 0.000 description 1
- 230000035897 transcription Effects 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L3/00—Containers or dishes for laboratory use, e.g. laboratory glassware; Droppers
- B01L3/50—Containers for the purpose of retaining a material to be analysed, e.g. test tubes
- B01L3/502—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures
- B01L3/5027—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures by integrated microfluidic structures, i.e. dimensions of channels and chambers are such that surface tension forces are important, e.g. lab-on-a-chip
- B01L3/502715—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures by integrated microfluidic structures, i.e. dimensions of channels and chambers are such that surface tension forces are important, e.g. lab-on-a-chip characterised by interfacing components, e.g. fluidic, electrical, optical or mechanical interfaces
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/80—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood groups or blood types or red blood cells
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2200/00—Solutions for specific problems relating to chemical or physical laboratory apparatus
- B01L2200/06—Fluid handling related problems
- B01L2200/0605—Metering of fluids
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2200/00—Solutions for specific problems relating to chemical or physical laboratory apparatus
- B01L2200/06—Fluid handling related problems
- B01L2200/0689—Sealing
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2300/00—Additional constructional details
- B01L2300/04—Closures and closing means
- B01L2300/041—Connecting closures to device or container
- B01L2300/043—Hinged closures
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2300/00—Additional constructional details
- B01L2300/08—Geometry, shape and general structure
- B01L2300/0809—Geometry, shape and general structure rectangular shaped
- B01L2300/0816—Cards, e.g. flat sample carriers usually with flow in two horizontal directions
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2300/00—Additional constructional details
- B01L2300/08—Geometry, shape and general structure
- B01L2300/0861—Configuration of multiple channels and/or chambers in a single devices
- B01L2300/0867—Multiple inlets and one sample wells, e.g. mixing, dilution
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2400/00—Moving or stopping fluids
- B01L2400/04—Moving fluids with specific forces or mechanical means
- B01L2400/0403—Moving fluids with specific forces or mechanical means specific forces
- B01L2400/0406—Moving fluids with specific forces or mechanical means specific forces capillary forces
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2400/00—Moving or stopping fluids
- B01L2400/06—Valves, specific forms thereof
- B01L2400/0633—Valves, specific forms thereof with moving parts
- B01L2400/0644—Valves, specific forms thereof with moving parts rotary valves
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2400/00—Moving or stopping fluids
- B01L2400/06—Valves, specific forms thereof
- B01L2400/0677—Valves, specific forms thereof phase change valves; Meltable, freezing, dissolvable plugs; Destructible barriers
- B01L2400/0683—Valves, specific forms thereof phase change valves; Meltable, freezing, dissolvable plugs; Destructible barriers mechanically breaking a wall or membrane within a channel or chamber
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L3/00—Containers or dishes for laboratory use, e.g. laboratory glassware; Droppers
- B01L3/50—Containers for the purpose of retaining a material to be analysed, e.g. test tubes
- B01L3/502—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures
- B01L3/5027—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures by integrated microfluidic structures, i.e. dimensions of channels and chambers are such that surface tension forces are important, e.g. lab-on-a-chip
- B01L3/502707—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures by integrated microfluidic structures, i.e. dimensions of channels and chambers are such that surface tension forces are important, e.g. lab-on-a-chip characterised by the manufacture of the container or its components
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L9/00—Supporting devices; Holding devices
- B01L9/52—Supports specially adapted for flat sample carriers, e.g. for plates, slides, chips
- B01L9/527—Supports specially adapted for flat sample carriers, e.g. for plates, slides, chips for microfluidic devices, e.g. used for lab-on-a-chip
Definitions
- the invention relates to a test device intended for carrying out a biological or chemical reaction between at least one fluid and at least one reactive agent, an assembly comprising two devices of this type as well as its implementation method.
- the change in the physico-chemical properties of the fluid can for example lead to the formation of identifiable agglutinates or to a change in color of said fluid.
- such a reaction makes it possible to determine the blood group, and in particular the pre-transfusion compatibility test between the blood of a recipient and that of a donor.
- Such tests aim to demonstrate the presence in blood samples of type A, B or AB antigens with a view to characterizing blood samples in a conventional manner according to types A, B, AB and O. Determination of the Rhesus factor , positive or negative, is carried out identically by demonstrating the presence or absence of an Rh antigen in the blood sample.
- Any blood transfusion requires from the medical professionals the assurance of the compatibility between the patient's blood group and that of the donor whose blood collected in a pocket will be transfused to said patient.
- a classic method of carrying out pre-transfusion accounting tests is based on the agglutination of group A, B or AB red cells by anti-A antibodies. and / or anti-B, then visual and comparative observation of the results of agglutination between the blood sample of the donor and that of the recipient.
- the reading of the test is carried out in indicator chambers which, in the case of a negative reaction, are filled with the fluid and otherwise are not filled due to the obstruction of the capillary narrowed by agglutinates.
- the invention therefore aims to remedy these drawbacks by proposing a completely reliable test device, simple to manufacture and the implementation of which requires no specific preparation step of the sample to be tested so as to ensure a level of hygiene. and optimal security.
- the device according to the invention is perfectly integrated in that the reactive agents are arranged for manufacturing, and is inexpensive to respond to its disposable nature.
- the invention provides a test device intended for carrying out a biological or chemical reaction between at least one fluid, in particular biological, and at least one reactive agent, said device comprising a part base and a top part intended to be associated with each other so as to define a capillary circuit between them, characterized in that the capillary circuit comprises at least one chamber intended to contain the reactive agent, said chamber being connected to an upstream capillary conduit allowing its supply of fluid and to a downstream capillary conduit allowing the flow of the fluid added with the reactive agent.
- the downstream capillary conduit is connected by its downstream part to a reading chamber intended to be able to determine the result of the test and an overflow chamber comprising a vent is associated with the reading chamber.
- the upstream capillary duct is connected by its upstream part to a first cavity intended to receive the fluid to be tested, said first cavity being formed in the base part.
- a portion of capillary conduit is associated on the one hand with the upstream capillary conduit and on the other hand with a second cavity intended to receive a second fluid, for example a solute allowing the dilution and the entrainment of the fluid to be tested in the capillary circuit , said second cavity being formed in the base part.
- a second fluid for example a solute allowing the dilution and the entrainment of the fluid to be tested in the capillary circuit , said second cavity being formed in the base part.
- the capillary circuit further comprises a second chamber containing a second reagent, the capillary conduits upstream of each of the chambers containing the reagents being associated via a junction, for example in T, so as to present a common upstream part through which the fluids are supplied.
- a fluid supply device disposed in the first cavity, comprises a needle intended to allow the piercing of a tubing containing the fluid to be tested, and a movable part which can be actuated manually in rotation between a first position called the “receiver” position in which said movable part covers said needle and a second position called the “donor” position in which said movable part is released from said needle so as to leave its free access.
- the needle has a notch which extends vertically from the tip part to the base part of said needle, said notch being arranged in the vicinity of the upstream end of the capillary circuit so as to allow the supply of said capillary circuit with fluid to be tested.
- the part movable in rotation comprises a lever, the first end part of which is fixed in rotation in the first cavity and a cap disposed in the vicinity of the second end part of said lever, said cap being intended to cover the needle.
- the cap has a hole, so as to allow the capillary circuit to be supplied with the fluid to be tested when said cap covers the needle.
- the device further comprises a cover associated with the base part by means of fastening means in rotation.
- the cover comprises two windows placed substantially opposite the reading chambers when the cover is closed on the base part so as to leave said chambers visible.
- the cover comprises, on its inner face and arranged opposite the needle, a tubing holder made up of four pins allowing the maintenance and the pressurization of a segment of tubing containing the fluid to be tested, so that when the lid is closed the needle pierces the tubing to supply the capillary circuit with the fluid to be tested.
- At least one tooth is placed in the second cavity and in that a reservoir closed by a pierceable film and containing the second fluid is placed in the cover opposite said tooth, so that when the cover is closed the tooth pierces the film to supply the capillary circuit with second fluid.
- the invention provides an assembly allowing a pre-transfusion blood compatibility test comprising two devices as described above which have been associated with each other, the first device being intended for determining the blood group of the recipient and the second device to that of the donor.
- the invention proposes a method for carrying out a pre-transfusion blood compatibility test using such an assembly comprising the steps of:
- Figure 1 is a perspective view showing a test device according to the invention in "receiver" configuration, before closing the cover to perform the test.
- FIG. 2 is a plan view of the base part and of the top part associated with it, the device also being in "receiver" configuration and the base part being transparent so as to see the capillary circuit.
- Figure 3 is a cross-sectional view along line III-III of Figure 2, showing the device in "receiver” configuration with the cover closed.
- Figure 4 is a detail view of part IV of Figure 3, showing more particularly the fluid supply device in "receiver" configuration.
- Figure 5 is a cross-sectional view along line V-V of Figure 2, showing part of the capillary circuit in section with the cover closed.
- Figure 6 is a detail view of part VI of Figure 5, showing more particularly the chamber for receiving the reactive agent.
- the test device intended for carrying out a reaction between at least one fluid and at least one reactive agent comprises a base part 1 and a top part 2.
- base and “top” are defined relative to the position of use of the test device, as illustrated in FIG. 1.
- the base 1 and top 2 parts are intended to be associated with one another so as to define a capillary circuit 3 between them.
- the association is made in particular by welding the periphery of the base 1 and top 2 parts together so as to seal the capillary circuit 3 when the fluid circulates inside.
- the base 1 and top 2 parts are produced by a rectangular plate of plastic material on which the path of the capillary circuit 3 has been formed, for example by molding.
- the trace on the base plate 1 is made in negative, that is to say essentially recessed on the base plate, and the trace on the top plate 2 is made in positive, that is to say essentially in a protruding manner relative to the top plate 2.
- the base part 1 further comprises a first cavity 4 intended to receive the fluid to be tested and a second cavity 5 intended to receive a second fluid, for example a solute allowing the dilution and the entrainment of the fluid to be tested in the capillary circuit.
- the second fluid may also have an active role in the reaction, for example adjusting the pH in order to optimize the reaction, while ensuring the preservation of the cellular integrity of the fluid to be tested.
- the two cavities 4, 5 are produced during the formation of the trace of the capillary circuit 3 on the base part 1.
- the two cavities 4, 5 are fluidly connected to the capillary circuit 3. This connection is produced by associating a portion of capillary conduit 6, 7 respectively with each of these cavities 4, 5 so that the fluid which is introduced therein can supply the circuit capillary 3.
- the size of the top part 2 is arranged so as to allow free access to the two cavities 4, 5 when this one is associated with the base part 1, so that the fluid to be tested and / or the second fluid can be introduced into their respective cavities 4, 5.
- the cavities 4, 5 are produced at the periphery of two adjacent sides of the base part 1 and the top part 2 is associated eccentrically with respect to the base part 1 by tangent the two cavities 4, 5.
- the device has no cavity 4.
- the capillary circuit 3 is then directly supplied with fluid, for example an orifice can be provided in the capillary circuit 3 into which the fluid is introduced in particular by gravity.
- capillary circuit 3 comprising capillary conduits, two chambers 8, 9 intended to contain a reactive agent, two reading chambers 10, 11 and two overflow chambers 12, 13 associated respectively reading rooms 10, 11.
- upstream and downstream are defined with respect to the direction of circulation of the fluid in the test device, that is to say from the cavities 4, 5 towards the reading chambers 10, 11.
- the upstream part of the capillary circuit 3 is bifid in that it comprises two portions of capillary conduits 6, 7 associated, by their upstream end, respectively with a cavity 4, 5, and by their downstream end, between them by means of a junction 14. This configuration makes it possible to supply the capillary circuit 3 on the one hand with the fluid to be tested and on the other hand with the second fluid.
- a single capillary conduit 15, in which the fluid to be tested and the second fluid mixes, makes it possible to bring the fluid to a second junction 16, for example in T, with capillary conduits 17 , 18 upstream allowing the supply of fluid to each of the chambers 8, 9 intended to contain a reactive agent.
- the expression “the fluid” designates the mixture between the fluid to be tested and the second fluid.
- the junction 16 makes it possible to supply fluid to each of the chambers 8, 9 intended to contain a reagent while avoiding the mixing of the reagents.
- the height of the single capillary conduit 15 can be greater than that of the two capillary conduits 17, 18 supplying the chambers 8, 9.
- reaction can modify other physicochemical properties of the fluid, such as for example its color, provided that this modification can be identified in the reading chambers 10, 11.
- the two chambers 8, 9 are identical and have a generally cylindrical shape with a diameter greater than the width of the duct. capillary 17, 18, and of height substantially identical to that of the upstream and downstream capillaries.
- the two chambers 8, 9 can have different shapes and / or internal structures.
- a projection 19 is inserted inside the chamber 8, 9 so as to create a partial obstacle to the flow of the fluid in the capillary circuit 3.
- This projection 19 is for example obtained by molding in the top part 2.
- the height of the projection 19 is substantially the same as that of the chamber 8, 9 and its diameter is less than that of the chamber 8, 9.
- the projection 19 then comes into substantial abutment on the bottom of the chamber 8, 9.
- Such a configuration forces the fluid to bypass the projection 19 to pass from the upstream part to the downstream part of the chamber 8, 9.
- the path bypassing the projection 19 then forms a capillary portion which has a height and a width substantially identical to those of the upstream and downstream capillaries.
- the projection 19 is arranged concentrically with the chamber 8, 9 so that the fluid arriving in the upstream part of the chamber 8, 9 bypasses the projection 19 to arrive in the downstream part of the chamber 8, 9
- This configuration makes it possible in particular to improve the contact between the fluid and the reactive agent and therefore their mixture.
- the reactive agent can be placed, in particular in dehydrated form, on the external wall of the projection 19 so that the fluid comes to rehydrate it when it comes into contact with the projection 19.
- the arrangement of the reactive agent is then carried out after the molding of the top part 2 and prior to its association with the base part 1.
- the height of the two chambers 8, 9 may be greater than that of the upstream and downstream capillaries and / or the height of the projection 19 may be less than that of the chamber 8, 9, in particular so that the arrangement of the projection 19 inside the chamber 8, 9 leaves a free space between the end of said projection 19 and the bottom of the chamber 8, 9.
- the height of this free space is substantially the same than that of the upstream and downstream capillaries. The fluid arriving in the upstream part of the chamber 8, 9 then passes through this free space and around the projection 19 to supply the downstream capillaries.
- a capillary conduit 20, 21 Downstream of each of the chambers 8, 9, a capillary conduit 20, 21 is associated so as to allow the flow of the fluid added with the reactive agent, the downstream part of this conduit 20, 21 being associated respectively with a reading 10, 11.
- this capillary duct 20, 21 is sinuous and has a significant curvature so as to allow time for the reaction to occur before the mixture arrives in the reading chamber 10, 11.
- the general structure of the capillary circuit 3 also takes account of a concern for the compactness of the device so as to provide an easily manipulated device.
- the reading chamber 10, 11 has a substantially parallelepiped shape with a length and a height sufficient to allow viewing of the agglutinates by the operator.
- At least the portion of the top part 2 forming the reading chamber 10, 11 is made of transparent plastic material.
- the transparent plastic material has a magnifying effect directly above the reading chambers 10, 11 so as to better visualize the result of the test.
- the base 1 and top 2 parts are made of transparent plastic material based on polycarbonate resin, polystyrene, polymethyl methacrylate, optionally added with additives to optimize their physicochemical and / or biological properties, and in particular to improve the effect of capillary forces.
- an overflow chamber 12, 13 Downstream of each of the reading chambers 10, 11, an overflow chamber 12, 13 is arranged opposite the capillary conduit 20, 21 via a portion of capillary conduit 22, 23.
- the chambers overflow 12, 13 and / or the capillary conduit portions 22, 23 have on the one hand a height greater than that of reading chambers 10, 11 and, on the other hand, a vent 24 disposed opposite them so as to stop the flow of fluid in the capillary circuit 3, while ensuring its sealing.
- vent 24 allows the release of the air contained in the capillary circuit 3 which allows the fluid to flow optimally therein.
- all the capillary conduits of the capillary circuit 3 have, in cross section, a substantially trapezoidal shape with a substantially constant height and between 100 ⁇ m and 500 ⁇ m.
- shape and size of the capillary conduits depend on the nature of the fluid to be tested, on the possible presence of a second fluid, as well as on the nature of the agglutinates formed during the test reaction.
- the size of the capillary conduits 20, 21 downstream of the chamber must be substantially greater than that of the agglutinates so as to avoid any occlusion of the device and to allow the action of capillary forces.
- the length of the capillary conduits 17, 18 upstream of the chamber 8, 9 can be adjusted by a person skilled in the art as a function of the time for obtaining a good mixture between the fluid to be tested and the second fluid, and that 20, 21 downstream of the chambers 8, 9 as a function of the reaction time between the fluid and the reactive agent.
- the capillary circuit 3 has a symmetrical structure downstream of the junction 16 so as to obtain a length of capillary conduit 20, 21 identical between said junction 16 and each of the reading chambers 10, 1 1.
- This configuration makes it possible to obtain a substantially identical fluid flow time from junction 16 to one of the two reading chambers in order to allow simultaneous reading 10, 1 1 of the results in each of said chambers 10, 1 1.
- test device uses the capillary forces to ensure the movement of the fluids in the capillary circuit 3 but also to allow the mixing of the fluids and the optimization of the reaction between the fluid and the reactive agent.
- the device further comprises a device 25 for supplying fluid to be tested, disposed in the first cavity 4 of the base part 1.
- the supply device 25 is arranged to directly supply the orifice of the capillary circuit 3 with the fluid to be tested.
- the device 25 comprises on the one hand a needle 26, for example molded in the cavity 4 of the base part 1 during the formation of the trace of the capillary circuit 3, said needle 26 being intended to allow the piercing of a tubing containing the fluid to be tested, and on the other hand a movable part 27 which can be actuated manually in rotation between a first position in which said movable part 27 covers said needle 26 and a second position in which said movable part 27 is released from said needle 26 so to give free access.
- a needle 26 for example molded in the cavity 4 of the base part 1 during the formation of the trace of the capillary circuit 3, said needle 26 being intended to allow the piercing of a tubing containing the fluid to be tested
- a movable part 27 which can be actuated manually in rotation between a first position in which said movable part 27 covers said needle 26 and a second position in which said movable part 27 is released from said needle 26 so to give free access.
- the needle 26 has a notch 28 which extends vertically from the tip part 29 to the base part 30 of said needle 26, said notch 28 being disposed in the vicinity of the end upstream of the capillary circuit 3 so as to allow the supply of said circuit 3 with fluid to be tested.
- a tube for example made of flexible plastic material, containing the fluid to be tested is brought to the tip 29 of the needle 26 so that the latter pierces the tube.
- the fluid to be tested can then flow by gravity, along the notch 28, from the tip part 29 to the base part 30 where it can then supply the capillary circuit 3.
- the mobile part 27 in rotation comprises a lever 31, the first end part 32 of which is fixed in rotation in the first cavity 4, for example by snap-fastening, and a cap 33 disposed in the vicinity of the second end part 34 of said lever 31, said cap. 33 being intended to cover the needle 26.
- the cap 33 is pierced with a hole 35 so as to allow the capillary circuit 3 to be supplied with the fluid to be tested when the said cap 33 covers the needle 26.
- This configuration makes it possible to define two extreme positions for the supply device.
- the first so-called “receiver” position in which the cap 33 covers the needle 26.
- the capillary circuit 3 is then supplied by introducing a drop of fluid to be tested into the hole 35 of the cap 33 so that said drop reaches the tip portion 29 of the needle 26 and then be guided by the notch 28 to the entry of the capillary circuit 3.
- the second extreme position called the "donor" position in which the cap 33 is distant from said needle 26 by so as to leave its free access.
- the capillary circuit 3 is then supplied by a tube which is pierced by said needle 26. The passage between these two extreme positions is carried out by simple manual action of the operator, in particular by rotation of 180 ° of the movable part 27.
- the default position of the feed device is the “receiver” position so as to avoid the operator being able to injure himself with the needle 26 while handling the test device.
- the device further comprises a cover 36 associated with the base part 1 by means of fixing means 37 in rotation, for example of the hinge type, provided on one side respectively of the base part 1 and cover 36.
- the cover 36 is for example made of plastic material, transparent or not, and has a skirt 38 capable of coming to cover at least the periphery of the assembly formed by the base parts 1 and top 2 associated.
- the fixing means 37 in rotation allow, by simple manual action, either to open the device ( Figure 1) so as to leave free access to the two cavities 4, 5, or to close it so that the cover 36 covers the 'assembly formed by the base parts 1 and top 2 associated.
- the supply device 25 can also be covered by the cover 36.
- complementary means prevent the operator from reopening the cover 36 once it has been closed.
- the cover 36 comprises two windows 39, 40 placed substantially opposite the reading chambers 10, 11 when the cover 36 is closed on the base part 1 so as to leave the said chambers 10, 11 visible.
- the cover 36 comprises, on its inner face and disposed opposite the needle 26, a tubing holder 41 consisting of four pins 42 allowing the maintenance and pressurization of a segment of tubing containing the fluid to be tested, so that when the cover 36 is closed the needle 26 pierces the tubing to supply the capillary circuit 3 with the fluid to be tested.
- the tubing holder 41 also allows the use of tubing whose diameter is very variable.
- the inner face of the cover 36 further comprises a reservoir 43 closed by a pierceable film and containing the second fluid.
- the reservoir 43 is formed by four walls arranged on the face of the cover 36 so as to delimit a quadrilateral space between them.
- a film, for example of aluminum, is glued in a leaktight manner on said walls so as to close said space which has been previously filled with the second fluid.
- teeth 44 for example of triangular section, are provided, so that when the cover 36 is closed the teeth 44 pierce the film to fill the second cavity 5 with second fluid. so as to supply the capillary circuit 3 with said fluid.
- a label can be provided so as to specify the characteristics of the test that can be performed and / or allow the operator to write information on the performance or the result of the test.
- the label also includes information concerning the substance tested in each reading window 10, 11, for example, in the case of the determination of the blood group, the inscriptions “Anti-A” and “Anti-B” placed respectively at proximity of each corresponding window 10, 11
- test device shown in FIG. 1 is briefly described below.
- the operator chooses to put the supply device in the "donor” position or in the "receiver” position by actuating the lever 31.
- the operator closes the cover 36 on the assembly formed on the one hand by the base 1 and top 2 parts and on the other hand by the supply device 25.
- the rotation of the supply device 25 must be sufficient not to interfere with the closing of the cover 36.
- it is impossible to close the cover 36 if the operator has not chosen between the “recipient” position or the “donor” position.
- This action marks the start of the test. Indeed, it allows the teeth 44 to pierce the film of the reservoir 43 so as to supply the capillary circuit 3 with a second fluid.
- the supply device 25 is in the “donor” position, the tubing is pierced by the needle 26 in order to supply the capillary circuit 3 with the fluid to be tested.
- This simultaneous supply of the two fluids makes it possible to initiate the test by causing the fluids to flow in the capillary circuit 3 under the action of capillary forces.
- the two fluids then mix inside the capillary conduits, upstream of the junction 16, then the fluid will mix with the reagent present respectively in each chamber 8, 9.
- the mixture formed of the fluid and the reagent then flows into the conduit 20, 21 located downstream of the chambers 8, 9 so that, under the action of capillary forces, the reaction can occur.
- the operator can then see, after a few seconds, in each of the reading chambers 10, 11, the presence or absence of agglutinates so as to characterize the result of the reaction as a function of the substance tested.
- the fluid possibly in excess relative to the volume of the reading chambers 10, 11 will then fill the overflow chambers 12, 13 which makes it possible to stop the flow of the fluid.
- the use of the device according to the invention is simple and integrated in that it requires only one step of supplying the fluid to be tested and that the test is then carried out automatically after closing the cover 36.
- This device also meets safety and reliability criteria in that the operator has no direct contact with the fluid to be tested or with the reactive agents.
- the device can be produced with reduced dimensions so as to facilitate its handling and / or its storage.
- the device is of rectangular shape and its dimensions are, once the cover 36 closed, 64.75 mm in length, 52.4 mm in width and 12.5 mm in height.
- the device After use and transcription of the test result, the device is destroyed, for example by incineration, so that the device according to the invention is for single use.
- the device is used to perform blood grouping A and / or B.
- the first chamber 8 then contains an anti-A reagent and the second chamber 9 an anti-B reagent, the two reagents being for example under a dehydrated form and of monoclonal origin.
- the fluid to be tested is then preferably whole blood.
- This blood can be collected in a blood bag provided with a tubing able to be introduced into the tubing holder 41 of the device.
- the supply device 25 is then placed in the "donor" position.
- the blood can also be taken directly, for example by puncturing the vein using a syringe or after drawing at the fingertip, and introduced into the supply device 25 in the "recipient" position.
- the second fluid is a buffered isotonic solution.
- the monoclonal antibodies contained in these reagents will be able to react with the antigens which correspond to them and thus cause an agglutination of red blood cells which is visible to the naked eye.
- the operator observes agglutination in the reading chamber 10 communicating with the chamber containing the Anti-A reagent and a uniformly red suspension in the other reading chamber 11, he can then deduce therefrom that the blood tested is of group A.
- the device according to the invention allows a pre-transfusion blood count test to be carried out between a donor and a recipient.
- the base part then comprises association means 45, in particular irreversible, of a second test device which are for example arranged on the side opposite to the cover 36.
- the operator then combines two devices according to the invention so as to form an assembly.
- the first device is intended for determining the blood group of the recipient whose blood is collected directly. The operator then places this device in the "receiver” position. The first device is intended for determining the blood group of the recipient whose blood is collected directly. The operator then places this device in the "receiver” position.
- the second device is intended for determining the blood group of the donor whose blood is contained in a pocket. The operator then places this device in the "donor" position.
- the operator compares the result of each device so as to determine whether it is identical or not.
- the blood of the donor and that of the recipient are compatible, transfusion is therefore possible. Otherwise there is a blood incompatibility between the donor and the recipient.
- more than two devices can be associated, in particular in the case of transfusion of several blood bags to a recipient.
- one device is put in the "recipient” position and the others in the "donor” position and each device
- Donor is associated, for example successively, with the "recipient” device so that the results of the tests can be compared.
- the recipient's blood test can be performed only once, in particular in the case where the transfusion of the various bags is carried out in a fairly short period of time.
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Urology & Nephrology (AREA)
- Analytical Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Cell Biology (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Microbiology (AREA)
- Clinical Laboratory Science (AREA)
- Dispersion Chemistry (AREA)
- Food Science & Technology (AREA)
- Biotechnology (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Automatic Analysis And Handling Materials Therefor (AREA)
Abstract
Description
Claims
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2001237511A AU2001237511A1 (en) | 2000-02-29 | 2001-02-28 | Biological or chemical testing device |
EP01909921A EP1259826A1 (fr) | 2000-02-29 | 2001-02-28 | Dispositif de test biologique ou chimique |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR00/02560 | 2000-02-29 | ||
FR0002560A FR2805476B1 (fr) | 2000-02-29 | 2000-02-29 | Dispositif de test biologique ou chimique |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2001065265A1 true WO2001065265A1 (fr) | 2001-09-07 |
Family
ID=8847544
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/FR2001/000580 WO2001065265A1 (fr) | 2000-02-29 | 2001-02-28 | Dispositif de test biologique ou chimique |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP1259826A1 (fr) |
AU (1) | AU2001237511A1 (fr) |
FR (1) | FR2805476B1 (fr) |
WO (1) | WO2001065265A1 (fr) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109475869A (zh) * | 2016-07-18 | 2019-03-15 | 西门子医疗保健诊断公司 | 液体分析试剂分配设备及其相关的分析套件和使用方法 |
CN112113955A (zh) * | 2020-09-15 | 2020-12-22 | 四川行之智汇知识产权运营有限公司 | 血红蛋白检测卡 |
CN112213301A (zh) * | 2020-09-15 | 2021-01-12 | 四川行之智汇知识产权运营有限公司 | 用于血液中血红蛋白的采集和检测装置 |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0350792A1 (fr) * | 1988-07-13 | 1990-01-17 | Kawasumi Laboratories, Inc. | Dispositif pour prélever du sang à tester |
US4948562A (en) * | 1985-09-04 | 1990-08-14 | Lacaille Yves M | Device for determining a blood group |
US5019351A (en) * | 1988-04-29 | 1991-05-28 | Hoffman-La Roche Inc. | Agglutination reaction slide |
DE9314161U1 (de) * | 1993-09-20 | 1993-12-16 | Nienhaus, Martin, Dr., 14169 Berlin | Vorrichtung zur Überprüfung der ABO-Identität von Spenderblut |
US5500187A (en) * | 1992-12-08 | 1996-03-19 | Westinghouse Electric Corporation | Disposable optical agglutination assay device and method for use |
DE29500587U1 (de) * | 1995-01-17 | 1996-05-15 | Schreiber, Hans, Dr. Dr., 69469 Weinheim | Bausatz insbesondere zur Blutgruppenbestimmung |
FR2762095A1 (fr) * | 1997-04-15 | 1998-10-16 | Univ Paris Curie | Dispositif de test biologique ou chimique, en particulier pour determiner le groupe sanguin d'un patient, susceptible d'etre porte a ou dans la ou les main(s), et procede de determination du groupe sanguin d'un patient s'y rapportant |
-
2000
- 2000-02-29 FR FR0002560A patent/FR2805476B1/fr not_active Expired - Fee Related
-
2001
- 2001-02-28 WO PCT/FR2001/000580 patent/WO2001065265A1/fr not_active Application Discontinuation
- 2001-02-28 EP EP01909921A patent/EP1259826A1/fr not_active Withdrawn
- 2001-02-28 AU AU2001237511A patent/AU2001237511A1/en not_active Abandoned
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4948562A (en) * | 1985-09-04 | 1990-08-14 | Lacaille Yves M | Device for determining a blood group |
US5019351A (en) * | 1988-04-29 | 1991-05-28 | Hoffman-La Roche Inc. | Agglutination reaction slide |
EP0350792A1 (fr) * | 1988-07-13 | 1990-01-17 | Kawasumi Laboratories, Inc. | Dispositif pour prélever du sang à tester |
US5500187A (en) * | 1992-12-08 | 1996-03-19 | Westinghouse Electric Corporation | Disposable optical agglutination assay device and method for use |
DE9314161U1 (de) * | 1993-09-20 | 1993-12-16 | Nienhaus, Martin, Dr., 14169 Berlin | Vorrichtung zur Überprüfung der ABO-Identität von Spenderblut |
DE29500587U1 (de) * | 1995-01-17 | 1996-05-15 | Schreiber, Hans, Dr. Dr., 69469 Weinheim | Bausatz insbesondere zur Blutgruppenbestimmung |
FR2762095A1 (fr) * | 1997-04-15 | 1998-10-16 | Univ Paris Curie | Dispositif de test biologique ou chimique, en particulier pour determiner le groupe sanguin d'un patient, susceptible d'etre porte a ou dans la ou les main(s), et procede de determination du groupe sanguin d'un patient s'y rapportant |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109475869A (zh) * | 2016-07-18 | 2019-03-15 | 西门子医疗保健诊断公司 | 液体分析试剂分配设备及其相关的分析套件和使用方法 |
US11040350B2 (en) | 2016-07-18 | 2021-06-22 | Siemens Healthcare Diagnostics Inc. | Liquid analytical reagent dispensing apparatus and analytical kits and methods of use related thereto |
CN112113955A (zh) * | 2020-09-15 | 2020-12-22 | 四川行之智汇知识产权运营有限公司 | 血红蛋白检测卡 |
CN112213301A (zh) * | 2020-09-15 | 2021-01-12 | 四川行之智汇知识产权运营有限公司 | 用于血液中血红蛋白的采集和检测装置 |
CN112113955B (zh) * | 2020-09-15 | 2022-03-18 | 四川行之智汇知识产权运营有限公司 | 血红蛋白检测卡 |
CN112213301B (zh) * | 2020-09-15 | 2022-03-18 | 四川行之智汇知识产权运营有限公司 | 用于血液中血红蛋白的采集和检测装置 |
Also Published As
Publication number | Publication date |
---|---|
FR2805476B1 (fr) | 2002-12-27 |
AU2001237511A1 (en) | 2001-09-12 |
EP1259826A1 (fr) | 2002-11-27 |
FR2805476A1 (fr) | 2001-08-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20200276577A1 (en) | Screening device for analysis of bodily fluids | |
US7294502B2 (en) | Device for collecting liquid samples | |
US11358142B2 (en) | Disposable cartridge for sample fluid analysis | |
BE1005090A5 (fr) | Dispositif d'echantillonnage et systeme d'adequation d'echantillon. | |
US20070025886A1 (en) | Biological specimen collection, transportation, and dispensing system | |
CA2575839A1 (fr) | Systeme de recuperation, transport et distribution d'un prelevement biologique | |
CA2717508A1 (fr) | Dispositif d'interfacage pour flacons a perforer a fins de preparations de liquides perfuses | |
WO2014191831A2 (fr) | Cartouche pour préparer un échantillon de fluide contenant des cellules à analyser | |
BR0209540B1 (pt) | Aparelho, cartucho e dispositivo de exame e uso do aparelho de exame | |
EP3021750A1 (fr) | Dispositif et procede d'echantillonnage et de distribution d'un fluide biologique utilisant un tube capillaire, et appareil d'analyse biologique | |
WO2011039430A2 (fr) | Dispositif a usage unique pour la detection de particules d'interet, telles que des entites biologiques, systeme de detection comprenant ledit dispositif et procede de mise en oeuvre | |
JP2001513897A (ja) | 流体試料の収集および試験装置 | |
EP0827427B1 (fr) | Dispositif et procede pour tests et analyses de fluides | |
WO2001065265A1 (fr) | Dispositif de test biologique ou chimique | |
US20160258943A1 (en) | Integrated Buffer Dual-Path Immunoassay Device | |
WO1998046136A1 (fr) | Seringue a compartiments multiples | |
EP0779103B1 (fr) | Dispositif de contrôle visuel d'un liquide par mélange avec un liquide réactif | |
FR3102558A1 (fr) | Système de dilution dans un dispositif et procédé de fabrication du dispositif | |
FR2630214A1 (fr) | Procede de selection de liquides pour la distribution de liquide d'un analyseur, et dispositif d'echantillonnage | |
WO2024218501A1 (fr) | Kits de test d'écoulement latéral | |
FR2948289A1 (fr) | Port d'injection et recipient a usage medical equipe d'au moins un tel port | |
WO2024218504A1 (fr) | Kits de test à flux latéral | |
EP1051617B1 (fr) | Dispositif jetable pour le prelevement d'un liquide biologique ou mineral avec detection et/ou dosage d'un parametre bien defini | |
WO2024218507A1 (fr) | Kits de test à flux latéral | |
WO2024134036A1 (fr) | Dispositif de collecte d'échantillon |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2001909921 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 2001909921 Country of ref document: EP |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 2001909921 Country of ref document: EP |
|
NENP | Non-entry into the national phase |
Ref country code: JP |